Cargando…

Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer's Disease versus Age-Matched Controls: A Presymptomatic Stage Study

Recent mouse studies of the presymptomatic stage of Alzheimer's disease (AD) have suggested that proinflammatory changes, such as glial activation and cytokine induction, may occur already at this early stage through unknown mechanisms. Because TNFα contributes to increased Aβ production from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doméné, Aurélie, Cavanagh, Chelsea, Page, Guylène, Bodard, Sylvie, Klein, Christophe, Delarasse, Cécile, Chalon, Sylvie, Krantic, Slavica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031839/ https://www.ncbi.nlm.nih.gov/pubmed/27672476 http://dx.doi.org/10.1155/2016/5696241

Ejemplares similares

Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer’s Disease
por: Mahar, Ian, et al.
Publicado: (2017)

Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson’s Disease Rat Model
por: Sérrière, Sophie, et al.
Publicado: (2015)

Upregulation of astrocytic α7 nicotinic receptors in Alzheimer's disease brain- possible relevant to amyloid pathology
por: Yu, Wenfeng, et al.
Publicado: (2012)

Amyloidosis in Retinal Neurodegenerative Diseases
por: Masuzzo, Ambra, et al.
Publicado: (2016)

Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model
por: Freyssin, Aline, et al.
Publicado: (2022)

Oxidative Stress Is Related to the Deleterious Effects of Heme Oxygenase-1 in an In Vivo Neuroinflammatory Rat Model
por: Tronel, Claire, et al.
Publicado: (2013)

Partial protective effects of melatonin on developing brain in a rat model of chorioamnionitis
por: Favrais, Geraldine, et al.
Publicado: (2021)

Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1
por: Foucault-Fruchard, Laura, et al.
Publicado: (2018)

Detection of Neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [(18)F]DPA-714 PET Imaging
por: Thomas, Clément, et al.
Publicado: (2016)

Complex role of chemokine mediators in animal models of Alzheimer's Disease
por: Martin, Elodie, et al.
Publicado: (2018)

The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer’s Disease and Aging: A Review of Knowledge
por: Rangon, Claire-Marie, et al.
Publicado: (2020)

Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport
por: Lagrue, Emmanuelle, et al.
Publicado: (2010)

Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson’s disease
por: Vetel, Steven, et al.
Publicado: (2020)

Trans ε viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model
por: Caillaud, Martial, et al.
Publicado: (2019)

Modeling Test and Treatment Strategies for Presymptomatic Alzheimer Disease
por: Burke, James F., et al.
Publicado: (2014)

Detection of presymptomatic Alzheimer's disease through breath biomarkers
por: Emam, Shadi, et al.
Publicado: (2020)

INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
por: Meyer, Pierre-François, et al.
Publicado: (2019)

Reply: Implications of presymptomatic change in thalamus and caudate in Alzheimer’s disease
por: Ryan, Natalie S., et al.
Publicado: (2013)

Public Willingness to Undergo Presymptomatic Genetic Testing for Alzheimer's Disease
por: Alanazy, Mohammed H., et al.
Publicado: (2019)

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
por: Bairamian, Diane, et al.
Publicado: (2022)

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
por: Weston, Philip S. J., et al.
Publicado: (2019)

Neural compensation in presymptomatic hAPP mouse models of Alzheimer's disease
por: Ammassari-Teule, Martine
Publicado: (2020)

Successful Cognitive Aging: Between Functional Decline and Failure of Compensatory Mechanisms
por: Verny, Marc, et al.
Publicado: (2015)

Distinct inflammatory phenotypes of microglia and monocyte‐derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology
por: Martin, Elodie, et al.
Publicado: (2016)

Concomitant Retinal Alterations in Neuronal Activity and TNFα Pathway Are Detectable during the Pre-Symptomatic Stage in a Mouse Model of Alzheimer’s Disease
por: Dinet, Virginie, et al.
Publicado: (2022)

Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer
por: Elie, Jonathan, et al.
Publicado: (2018)

Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study
por: Weston, Philip S.J., et al.
Publicado: (2016)

The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease
por: Li, Dan, et al.
Publicado: (2019)

Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice
por: Cruz, Nancy F, et al.
Publicado: (2010)

Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically
por: Paizs, Melinda, et al.
Publicado: (2011)

Natural stilbenes effects in animal models of Alzheimer’s disease
por: Freyssin, Aline, et al.
Publicado: (2019)

Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer's disease
por: Albuquerque, Marilia S., et al.
Publicado: (2015)

Conformation-Dependent Oligomers in Cerebrospinal Fluid of Presymptomatic Familial Alzheimer's Disease Mutation Carriers
por: Ringman, John M., et al.
Publicado: (2012)

Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer’s disease
por: Ryan, Natalie S., et al.
Publicado: (2013)

Emotion recognition of morphed facial expressions in presymptomatic and symptomatic frontotemporal dementia, and Alzheimer’s dementia
por: Jiskoot, Lize C., et al.
Publicado: (2020)

Plasma GFAP in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases
por: Freyssin, Aline, et al.
Publicado: (2018)

Impaired astrocytic Ca(2+) signaling in awake-behaving Alzheimer’s disease transgenic mice
por: Åbjørsbråten, Knut Sindre, et al.
Publicado: (2022)

Study of influence of the glutamatergic concentration of [(18)F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers
por: Dupont, Anne-Claire, et al.
Publicado: (2021)

Leptin-dependent neurotoxicity via induction of apoptosis in adult rat neurogenic cells
por: Segura, Stéphanie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f3ri0l6si5p078prk4grvois5k